Greg M. Delgoffe won a 2017 NIH Director's New Innovator Award

Greg M. Delgoffe, assistant professor of immunology at the University of Pittsburgh School of Medicine, will receive the 2017 NIH Director’s New Innovator Award for his groundbreaking research on immunotherapy in the tumor microenvironment.

Studies from the Delgoffe lab in the UPMC Hillman Cancer Center Tumor Microenvironment Center aim to provide energy to the T cells that can destroy the cancer cells and deplete the suppressive cells that may inhibit immunotherapy responses. This could lead to the development of new drugs that can enhance cancer immunotherapy.